Literature DB >> 17669420

Three members of the human pyruvate dehydrogenase kinase gene family are direct targets of the peroxisome proliferator-activated receptor beta/delta.

Tatjana Degenhardt1, Anna Saramäki, Marjo Malinen, Markus Rieck, Sami Väisänen, Anne Huotari, Karl-Heinz Herzig, Rolf Müller, Carsten Carlberg.   

Abstract

The nuclear receptors peroxisome proliferator-activated receptors (PPARs) are known for their critical role in the metabolic syndrome. Here, we show that they are direct regulators of the family of pyruvate dehydrogenase kinase (PDK) genes, whose products act as metabolic homeostats in sensing hunger and satiety levels in key metabolic tissues by modulating the activity of the pyruvate dehydrogenase complex. Mis-regulation of this tightly controlled network may lead to hyperglycemia. In human embryonal kidney cells we found the mRNA expression of PDK2, PDK3 and PDK4 to be under direct primary control of PPAR ligands, and in normal mouse kidney tissue Pdk2 and Pdk4 are PPAR targets. Both, treatment of HEK cells with PPARbeta/delta-specific siRNA and the genetic disruption of the Pparbeta/delta gene in mouse fibroblasts resulted in reduced expression of Pdk genes and abolition of induction by PPARbeta/delta ligands. These findings suggest that PPARbeta/delta is a key regulator of PDK genes, in particular the PDK4/Pdk4 gene. In silico analysis of the human PDK genes revealed two candidate PPAR response elements in the PDK2 gene, five in the PDK3 gene and two in the PDK4 gene, but none in the PDK1 gene. For seven of these sites we could demonstrate both PPARbeta/delta ligand responsiveness in context of their chromatin region and simultaneous association of PPARbeta/delta with its functional partner proteins, such as retinoidXreceptor, co-activator and mediator proteins and phosphorylated RNA polymerase II. In conclusion, PDK2, PDK3 and PDK4 are primary PPARbeta/delta target genes in humans underlining the importance of the receptor in the control of metabolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17669420     DOI: 10.1016/j.jmb.2007.06.091

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  39 in total

1.  CD36-dependent regulation of muscle FoxO1 and PDK4 in the PPAR delta/beta-mediated adaptation to metabolic stress.

Authors:  Zaher Nahlé; Michael Hsieh; Terri Pietka; Chris T Coburn; Paul A Grimaldi; Michael Q Zhang; Debopriya Das; Nada A Abumrad
Journal:  J Biol Chem       Date:  2008-02-28       Impact factor: 5.157

2.  PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia.

Authors:  Fabrizio Pin; Leah J Novinger; Joshua R Huot; Robert A Harris; Marion E Couch; Thomas M O'Connell; Andrea Bonetto
Journal:  FASEB J       Date:  2019-03-20       Impact factor: 5.191

3.  Genome-wide profiling of peroxisome proliferator-activated receptor γ in primary epididymal, inguinal, and brown adipocytes reveals depot-selective binding correlated with gene expression.

Authors:  Majken S Siersbæk; Anne Loft; Mads M Aagaard; Ronni Nielsen; Søren F Schmidt; Natasa Petrovic; Jan Nedergaard; Susanne Mandrup
Journal:  Mol Cell Biol       Date:  2012-06-25       Impact factor: 4.272

4.  Glucose oxidation modulates anoikis and tumor metastasis.

Authors:  Sushama Kamarajugadda; Lauren Stemboroski; Qingsong Cai; Nicholas E Simpson; Sushrusha Nayak; Ming Tan; Jianrong Lu
Journal:  Mol Cell Biol       Date:  2012-03-19       Impact factor: 4.272

5.  A new locus for X-linked dominant Charcot-Marie-Tooth disease (CMTX6) is caused by mutations in the pyruvate dehydrogenase kinase isoenzyme 3 (PDK3) gene.

Authors:  Marina L Kennerson; Eppie M Yiu; David T Chuang; Aditi Kidambi; Shih-Chia Tso; Carolyn Ly; Rabia Chaudhry; Alexander P Drew; Gary Rance; Martin B Delatycki; Stephan Züchner; Monique M Ryan; Garth A Nicholson
Journal:  Hum Mol Genet       Date:  2013-01-07       Impact factor: 6.150

6.  Lipolytic products activate peroxisome proliferator-activated receptor (PPAR) α and δ in brown adipocytes to match fatty acid oxidation with supply.

Authors:  Emilio P Mottillo; Ainsley E Bloch; Todd Leff; James G Granneman
Journal:  J Biol Chem       Date:  2012-06-08       Impact factor: 5.157

7.  PPARβ activation restores the high glucose-induced impairment of insulin signalling in endothelial cells.

Authors:  A M Quintela; R Jiménez; L Piqueras; M Gómez-Guzmán; J Haro; M J Zarzuelo; A Cogolludo; M J Sanz; M Toral; M Romero; F Pérez-Vizcaíno; J Duarte
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

8.  A metabolic prosurvival role for PML in breast cancer.

Authors:  Arkaitz Carracedo; Dror Weiss; Amy K Leliaert; Manoj Bhasin; Vincent C J de Boer; Gaelle Laurent; Andrew C Adams; Maria Sundvall; Su Jung Song; Keisuke Ito; Lydia S Finley; Ainara Egia; Towia Libermann; Zachary Gerhart-Hines; Pere Puigserver; Marcia C Haigis; Elefteria Maratos-Flier; Andrea L Richardson; Zachary T Schafer; Pier P Pandolfi
Journal:  J Clin Invest       Date:  2012-08-13       Impact factor: 14.808

9.  The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry.

Authors:  Fionnuala Morrish; Nicola Neretti; John M Sedivy; David M Hockenbery
Journal:  Cell Cycle       Date:  2008-02-08       Impact factor: 4.534

10.  Peroxisome proliferator-activated receptor beta activation promotes myonuclear accretion in skeletal muscle of adult and aged mice.

Authors:  C Giordano; A S Rousseau; N Wagner; C Gaudel; J Murdaca; C Jehl-Piétri; B Sibille; P A Grimaldi; P Lopez
Journal:  Pflugers Arch       Date:  2009-05-05       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.